<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11861558</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1316</article-id><article-id pub-id-type="other">EPV0665</article-id><article-id pub-id-type="pii">S0924933824013166</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>The importance of non-pharmacological approach versus pharmacological treatment of behavioral and psychological symptoms (bpsd) in patients with Alzheimer&#x02019;s dementia (AD) in a geriatric institution</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Spirova</surname><given-names>M.</given-names></name><xref rid="aff2930" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2930" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2931" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff2932" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cor1168" ref-type="corresp">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff2930"><sup>1</sup><institution>PHI Specialized Hospital for Geriatric and Palliative Medicine</institution>, <city>Skopje</city></aff><aff id="aff2931"><sup>2</sup><institution>PHI General hospital</institution>, <city>Kavadarci</city></aff><aff id="aff2932"><sup>3</sup><institution>PHI Health center Skopje</institution>, <city>Skopje</city>, <country>North Macedonia</country></aff><author-notes><corresp id="cor1168"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1291">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S635</fpage><lpage>S635</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824013166a.pdf"/><abstract><sec id="sec7021"><title>Introduction</title><p>BPSDs in patients with AD are present up to 90% and can cause serious complications in their overall health. A non-pharmacological approach and cognitive enhancers should be a priority in treatment in order to reduce the use of antipsychotics. In the pharmacological treatment of bpsd, additional therapy is inevitable in many cases</p></sec><sec id="sec7022"><title>Objectives</title><p>
the need for adequat educatation of the medical staff in a geriatric center for the nonfarmacological approach in patients with bpsd in AD. Polypharmacy is common in&#x000a0;farmacological treatment.</p></sec><sec id="sec7023"><title>Methods</title><p>A cross-sectional study of 180 patients hospitalized at geriatric unit in period of January till May 2023 was conducted. 61(33.9%) were patients with AD, 44 or 72.1% were females and 17 or 27.9% were males, with mean age 78.6&#x000b1;5.6 years. 50 patients (82.0%) had potentiated BPSD in the first days of hospitalization and needed additional therapy</p></sec><sec id="sec7024"><title>Results</title><p>: 19 od 61pts (31.1%) were on dual therapy, full doses of donepezil and memantine. 17 (89.5%) needed additional therapy for BPSD; 13 (68.4%) a short-term antipsychotic and 4 (21.1%) patients antidepressant therapy. 22 patients (36.1%) were admitted with donepezil only. 18 (81,8%) needed additional therapy. The remaining 20 (32,8%) were solely on memantine. 15 (75.0%) needed additional therapy</p></sec><sec id="sec7025"><title>Conclusions</title><p>Vast majority of patients AD (82.0%) manifested BPSD and needed additional therapy. Number of scientific papers it is found that cognitive stimulation in persons with moderate dementia has a benefit more than any pharmacological treatment. Education of caregivers of people with AD is inevitable.Opening of day care centers that will enable continuous support as well as individual access which would help delay institutionalization of people with BPSD at ADthe need</p></sec><sec id="sec7026"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>